Press Releases

Press Releases
Date Title and Summary View
Dec 7, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the Company's Quell® Wearable Pain Relief device is now available on Amazon Launchpad. Amazon Launchpad is a program that makes it easy for startups to launch, market, and distribute their ...
Nov 30, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the upcoming LD Micro Invitational at the Luxe Sunset Bel Air Hotel in Los Angeles, CA. Dr. Gozani intends to provide an update ...
Nov 29, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the CE (Conformité Européenne) Certificate for Quell® has been received from TŰV SŰD Product Service GmbH, which is one of the Notified Bodies responsible for reviewing and approving new product...
Nov 22, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO,NUROW) announced today that its Quell® Wearable Pain Relief Technology™ will be featured on the November 26th episode of The Henry Ford Innovation Nation which airs on the CBS network on Saturday mornings as part of its "CBS Dream ...
Nov 16, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Quell® Wearable Pain Relief Technology™ will be featured for the second year in a row at the American Society for Regional Anesthesia's Annual Pain Medicine Meeting to be held November 17-19 in San Diego, CA....
Nov 15, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) today reported that DPNCheck®, a diagnostic test for peripheral neuropathy, will be introduced at the 20th Scientific Meeting of the Chinese Diabetes Society during November 16-19, 2016 in Xiamen, Fujian, China. DPNCheck is registered ...
Nov 10, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Senior Vice President and Chief Commercial Officer Frank McGillin will present on Quell® Wearable Pain Relief Technology™ during the 16th Annual Diabetes Technology Meeting, November 10-12, in Bethesda, ...
Nov 8, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that it has promoted Frank McGillin to Senior Vice President and Chief Commercial Officer. Mr. McGillin's most recent title was Senior Vice President and GM Consumer. In the expanded role, Mr. McGillin will have primary ...
Oct 27, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,474,898. The patent covers key technology that enables safe delivery of Quell® therapy for chronic pain while the user is sleeping. Over 80% of chro...
Oct 25, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) announced today that Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer of NeuroMetrix, is scheduled to speak at the 2016 Sidoti Emerging Growth Convention at the Marriott Marquis in New York City on November 1, 2016...
FirstPrevious
3
... NextLast
Add to Briefcase = add release to Briefcase